Work

Influence of risk factors for renal cell carcinoma (RCC) on outcome of patients (pts) with metastatic disease (mRCC) treated with sunitinib (Su).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.e15058

Authors: Raanan Berger, Daniel Keizman, Maya Ish-Shalom, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Roberto Pili, Ben Boursi, Natalie Maimon, Maya Gottfried, Henry Hayat, Avivit Peer, Svetlana Kovel, Avishay Sella, Michael Anthony Carducci

Institutions: Sheba Medical Center, Tel Aviv University, Meir Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Roswell Park Comprehensive Cancer Center, Wolfson Medical Center, Rambam Health Care Campus, Assaf Harofeh Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4240525848

Cites:

Cited by: 1

Related to: 10